Viewing Study NCT03006159


Ignite Creation Date: 2025-12-24 @ 2:35 PM
Ignite Modification Date: 2026-01-24 @ 11:24 PM
Study NCT ID: NCT03006159
Status: COMPLETED
Last Update Posted: 2016-12-30
First Post: 2016-12-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 1, Randomized, Placebo-controlled, Multiple Dose Escalation Study to Investigate Safety, Pharmacokinetics, and Pharmacodynamics of SHR0534 in Chinese Type 2 Diabetic Patients
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module